Endothelial Dysfunction in Patients with Advanced Heart Failure Treated with Levosimendan Periodic Infusion Compared with Optimal Medical Therapy: A Pilot Study

Endothelial Dysfunction in Patients with Advanced Heart Failure Treated with Levosimendan Periodic Infusion Compared with Optimal Medical Therapy: A Pilot Study

Endothelial dysfunction (ED) is frequently found in patients with heart failure (HF). Among several pharmacological agents reported to improve endothelial function, levosimendan seems to be a promising one, even though, to date, only two previously published studies have evaluated its effects on ED...

Full description

Bibliographic Details
Main Authors: Alessandro Maloberti, Jinwei Sun, Jessica Zannoni, Lucia Occhi, Ilaria Bassi, Saverio Fabbri, Valentina Colombo, Elena Gualini, Michela Algeri, Marisa Varrenti, Gabriella Masciocco, Enrico Perna, Fabrizio Oliva, Manlio Cipriani, Maria Frigerio, Cristina Giannattasio
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Life
Subjects:
endothelial dysfunction
flow-mediated vasodilation
levosimendan
heart failure
Online Access:https://www.mdpi.com/2075-1729/12/9/1322

Internet

https://www.mdpi.com/2075-1729/12/9/1322

Similar Items